Skip to content
Featured on Startup Fame

Redcliffe Labs and Skyroot Aerospace test diagnostic reagents in space

Diagnostics startup Redcliffe Labs has partnered with spacetech company Skyroot Aerospace to conduct an experiment testing the stability and performance of diagnostic reagents in space. The first phase, named DRIFT-1, will expose dry diagnostic reagents to Low Earth Orbit for 90 days, with results compared to a control sample on Earth.

Editor, Lazyfounder

Published Updated 2 min read
Redcliffe Labs and Skyroot Aerospace test diagnostic reagents in space

KEY HIGHLIGHTS

  • Redcliffe Labs and Skyroot Aerospace have partnered to test diagnostic reagents in space.
  • The first experiment, DRIFT-1, will expose dry diagnostic reagents to Low Earth Orbit for 90 days.
  • The goal is to assess how space conditions affect the stability and performance of the reagents.
  • Redcliffe Labs was founded in 2018 and provides pathology and diagnostic services through laboratories, collection centers, and home sample collection.

Experiment details

According to Inc42, the collaboration’s first experiment, called DRIFT-1, will place Redcliffe Labs’ dry diagnostic reagents in Low Earth Orbit for 90 days. The reagents will be exposed to the space environment, including microgravity and radiation, to evaluate their stability and performance.

After the 90-day period, the performance of the space-exposed reagents will be compared to an identical control sample kept on Earth. The experiment aims to determine how space conditions might alter the reagents' effectiveness.

Redcliffe Labs’ background

Redcliffe Labs was founded in 2018 by Kandoi, Dheeraj Jain, and Ashish Dubey. The startup provides pathology and diagnostic services through a network of laboratories, collection centers, and home sample collection services, as reported by Inc42.

What this means

Lazyfounder analysis — our interpretation, not reported fact.

For founders and operators in diagnostics and spacetech, this experiment is a signal that extreme-environment testing could become a valuable R&D strategy. If the reagents perform well—or even reveal predictable degradation—it could lead to more robust products for use in remote or challenging conditions on Earth, such as disaster zones or rural areas. The collaboration also highlights a potential niche for startups: validating terrestrial technologies in space, which may attract interest from investors looking for innovative, cross-industry applications.

Key takeaways

  • This collaboration signals growing interest in validating healthcare technologies in extreme environments, which could open new R&D avenues for diagnostic startups.
  • Founders in the diagnostics and spacetech sectors may see opportunities for cross-industry innovation, particularly in areas like reagent stability and remote testing.
  • The experiment could provide data that enhances the reliability of diagnostic tools, potentially improving use cases in remote or resource-limited settings on Earth.

Sources

  1. inc42.com · 2026-08-14
    Redcliffe Labs, Skyroot Partner To Test Diagnostic Reagents In Space

This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.

About the author

Editor, Lazyfounder

Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.

More stories by Tarun Mottlia

Get the LazyFounder Brief

Startup, funding and AI news in a five-minute read. Join the early-access list.

Lazy Founder - Powered by Blogy.in

Contact us

Have a story tip, correction or partnership idea?

Write to us at tarun.kumar@blogy.in or talk to the founder directly. We read every message.

Contact us